Pharmaceuticals needed for patient care.
Ended Awarded
- Contract number
- HT009026FG1110036
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $36,087
Award facts
- Contract value 100% obligated
- $36,087.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6506 Blood And Blood Products
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
About this award
Sofie CO., doing business as IBA Molecular, received a Blanket Purchase Agreement (BPA) call award from the Defense Health Agency valued at $36,087.20 with a firm fixed-price structure and no set-aside designation. The contract, awarded on November 4, 2025, supports the delivery of pharmaceuticals needed for patient care, with performance to be completed by September 30, 2026, at the contractor's location in Sterling, Virginia. As a specialized supplier of molecular diagnostics and therapeutic radiopharmaceuticals, Sofie CO. provides critical diagnostic imaging agents including positron emission tomography (PET) imaging products to support medical treatment facilities serving military personnel and their families.
This BPA call order represents a task order issued under the Defense Health Agency's larger $6.5 million master blanket purchase agreement for pharmaceutical supplies with Sofie CO., established to enable streamlined procurement of radiopharmaceutical products. The Defense Health Agency has maintained this master BPA since February 2024 to facilitate ongoing access to specialized imaging and diagnostic pharmaceuticals across military treatment facilities. Sofie CO. is an established federal healthcare vendor with extensive experience delivering radiopharmaceuticals to the Department of Defense and Veterans Affairs, with a product portfolio including PYLARIFY for prostate cancer detection, NEURACEQ for Alzheimer's disease imaging, and various PET tracers for oncology and neuroendocrine tumor imaging applications.
Quick answers
Who was awarded contract HT009026FG1110036?
HT009026FG1110036 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on November 4, 2025.
How much is contract HT009026FG1110036 worth?
The government has obligated $36,087 on HT009026FG1110036.
Is contract HT009026FG1110036 an order under another contract?
Yes. HT009026FG1110036 is a BPA call under HT001424A0002, a blanket purchase agreement.
Was contract HT009026FG1110036 competed?
The extent of competition for HT009026FG1110036 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award